Determination of genotoxic-antigenotoxic effects of cultivated Ganoderma lucidum with the hen’s egg test for micronucleus induction
Abstract
Ganoderma lucidum is a mushroom used in alternative medicine worldwide, especially in China, and is also known as the “Mushroom of Immortality or Reishi”. In recent years, cultivated G. lucidum has also been produced in Türkiye and consumed by people, particularly in tablet, coffee, and tea form. One of the methods commonly used in genotoxicity tests is the micronucleus (MN) technique. Hen’s Egg Test for Micronucleus Induction (HET-MN) is a relatively new member of MN tests. HET-MN is an inexpensive, rapid, and extremely simple genotoxicity assay that is positioned between pure in vivo and in vitro analysis. This study aimed to determine, for the first time, the possible genotoxic-antigenotoxic effects of the aqueous extract at different doses of cultivated G. lucidum in Türkiye, using HET-MN as an alternative test method. G. lucidum aqueous extract at different doses (219 µg/egg, 875 µg/egg and 1750 µg/egg), vitamin C (50 µg/egg) as an antigenotoxic compound, and cyclophosphamide (50 µg/egg) as a genotoxic compound were injected separately and together into the fertilized chicken eggs at the 8th day of incubation. Blood smears were prepared from peripheral blood samples of the embryos and stained using the modified May- Grünwald–Giemsa method on the 11th day of incubation. In the smears, the frequencies of micronuclei and nuclear abnormalities in erythrocytes were determined under a light microscope. While the cultivated G. lucidum aqueous extract at the examined doses did not show a genotoxic effect, it exhibited an antigenotoxic effect. These results are consistent with another study that used wild-grown G. lucidum.
Keywords
Project Number
Ethical Statement
Thanks
References
- Cao, Q.-Z., & Lin, Z.-B. (2004). Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacologica Sinica, 25(6), 833-838.
- Chang, H.-M., But, P.P., & Yao, S.-C. (1986). Pharmacology and applications of Chinese materia medica. World Scientific Connect, 750 p.
- Çelik, B., & Özparlak, H. (2019). Determination of genotoxic and antigenotoxic effects of wild-grown Reishi mushroom (Ganoderma lucidum) using the hen’s egg test for analysis of micronucleus induction. Biotechnic & Histochemistry, 94(6), 628 636. https://doi.org/10.1080/10520295.2019.1622784
- Dai, S., Liu, J., Sun, X., & Wang, N. (2014). Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43. BMC Complementary and Alternative Medicine, 14(1), 434. https://doi.org/10.1186/1472-6882-14-434
- Deveci, E., Tel-Çayan, G., & Duru, M.E. (2019). Evaluation of phenolic profile, antioxidant and anticholinesterase effects of Fuscoporia torulosa. International Journal of Secondary Metabolite, 6(1), 79-89. https://dx.doi.org/10.21448/ijsm.496327
- Gopakumar, G., Martin, F., Antony, S.K., Pillai, T.G., & Nair, C.K.K. (2010). Preclinical studies on the use of medicinal mushroom Ganoderma lucidum as an adjuvant in radiotherapy of cancer. Current Science, 99(8), 1084-1090.
- Greywe, D., Kreutz, J., Banduhn, N., Krauledat, M., Scheel, J., Schroeder, K.R., Wolf, T., & Reisinger, K. (2012). Applicability and robustness of the hen's egg test for analysis of micronucleus induction (HET-MN): Results from an inter-laboratory trial. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 747, 118-134. https://doi.org/10.1016/j.mrgentox.2012.04.012
- Hothorn, L.A., Reisinger, K., Wolf, T., Poth, A., Fieblinger, D., Liebsch, M., & Pirow, R. (2013). Statistical analysis of the hen's egg test for micronucleus induction (HET-MN assay). Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 757, 68 78. https://doi.org/10.1016/j.mrgentox.2013.04.023
Details
Primary Language
English
Subjects
Structural Biology, Natural Products and Bioactive Compounds
Journal Section
Research Article
Authors
Döndü Balta Erkek
This is me
0009-0004-6634-6693
Türkiye
Haluk Özparlak
*
0000-0002-2333-0219
Türkiye
Early Pub Date
May 3, 2026
Publication Date
June 9, 2026
Submission Date
August 25, 2025
Acceptance Date
February 21, 2026
Published in Issue
Year 2026 Volume: 13 Number: 2